Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meg Doherty

Showing results (61-70 of 117) with videos related to

Pageof 12
Sort By:
The Lancet. HIV|May 13, 2022
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, et al.
AIDS (London, England)|November 8, 2017
Benefits and risks of rapid initiation of antiretroviral therapyNathan Ford, Chantal Migone, Alexandra Calmy, et al.
BMJ (Clinical Research Ed.)|February 19, 2020
WHO's path to elimination of mother-to-child transmission of HIV and syphilisNathan Shaffer, Melanie Taylor, Morkor Newman, et al.
The Pediatric Infectious Disease Journal|June 27, 2013
Mortality and long-term virologic outcomes in children and infants treated with lopinavir/ritonavirDora Estripeaut, Jon Mosser, Meg Doherty, et al.
Medicine|March 12, 2019
The Brazilian experience of implementing the active pharmacovigilance of dolutegravirCynthia Julia Braga Batista, Renato Girade Correa, Livia Ramalho Evangelista, et al.
Journal of the International AIDS Society|December 19, 2019
Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping reviewTamara Elliott, Eduard J Sanders, Meg Doherty, et al.
AIDS (London, England)|December 1, 2021
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?W D Francois Venter, Celicia Serenata, Marco Vitoria, et al.
Plos Medicine|November 30, 2016
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-AnalysisZara Shubber, Edward J Mills, Jean B Nachega, et al.
The Lancet. HIV|September 24, 2016
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysisSteve Kanters, Marco Vitoria, Meg Doherty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2019
Do Quality Improvement Initiatives Improve Outcomes for Patients in Antiretroviral Programs in Low- and Middle-Income Countries? A Systematic ReviewSally Hargreaves, Keiran Rustage, Laura B Nellums, et al.
Pageof 12

Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
The Lancet. HIV|May 13, 2022
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, et al.
AIDS (London, England)|November 8, 2017
Benefits and risks of rapid initiation of antiretroviral therapyNathan Ford, Chantal Migone, Alexandra Calmy, et al.
BMJ (Clinical Research Ed.)|February 19, 2020
WHO's path to elimination of mother-to-child transmission of HIV and syphilisNathan Shaffer, Melanie Taylor, Morkor Newman, et al.
The Pediatric Infectious Disease Journal|June 27, 2013
Mortality and long-term virologic outcomes in children and infants treated with lopinavir/ritonavirDora Estripeaut, Jon Mosser, Meg Doherty, et al.
Medicine|March 12, 2019
The Brazilian experience of implementing the active pharmacovigilance of dolutegravirCynthia Julia Braga Batista, Renato Girade Correa, Livia Ramalho Evangelista, et al.
Journal of the International AIDS Society|December 19, 2019
Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping reviewTamara Elliott, Eduard J Sanders, Meg Doherty, et al.
AIDS (London, England)|December 1, 2021
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?W D Francois Venter, Celicia Serenata, Marco Vitoria, et al.
Plos Medicine|November 30, 2016
Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-AnalysisZara Shubber, Edward J Mills, Jean B Nachega, et al.
The Lancet. HIV|September 24, 2016
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysisSteve Kanters, Marco Vitoria, Meg Doherty, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2019
Do Quality Improvement Initiatives Improve Outcomes for Patients in Antiretroviral Programs in Low- and Middle-Income Countries? A Systematic ReviewSally Hargreaves, Keiran Rustage, Laura B Nellums, et al.
Pageof 12